Eletriptan Hydrobromide
Who holds supplier records for Eletriptan Hydrobromide? 7 organisations hold a current record for Eletriptan Hydrobromide: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), Italy (1), Netherlands (1) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Eletriptan Hydrobromide: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/eletriptan-hydrobromide
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Eletriptan Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 25076, 24504 · latest filing Jun 2011
- SMS Pharmaceuticals limitedIndia Company GMP cert on recordActive DMF 42128, 24905 · latest filing Jul 2025
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 31336 · latest filing Jan 2017
- FIS FABBRICA ITALIANA SINTETICI SPAItaly Company GMP cert on recordActive DMF 24528 · latest filing Dec 2010
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 26099 · latest filing May 2012
- TAPI NL BVNetherlandsActive DMF 22912 · latest filing Jun 2009
- Tianjin Weijie Pharmaceutical Co., Ltd.ChinaActive DMF 30338 · latest filing Mar 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Eletriptan Hydrobromide are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Viwit Pharmaceutical Co., Ltd.China · Inactive DMF 27069 · filed Apr 2013
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 23651 · filed Mar 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Eletriptan Hydrobromide is a selective serotonin receptor agonist (triptan) used in the acute treatment of migraine headaches. It helps to relieve headache, pain, and other migraine symptoms, including nausea and sensitivity to light/sound.
Chemical identity
- IUPAC name
- 5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole;hydrobromide
- Canonical SMILES
- CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br
- InChIKey
- UTINOWOSWSPFLJ-FSRHSHDFSA-N
- Synonyms
- Relpax API, eletriptan hbr, nsc-759258, relpax, uk-116,044-04, uk-116044-04
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin-1b and Serotonin-1d Receptor Agonist
- Mechanism of action
- Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Eletriptan Hydrobromide?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Eletriptan Hydrobromide: MATRIX PHARMACORP PRIVATE LTD (India), SMS Pharmaceuticals limited (India), APITORIA PHARMA PRIVATE LTD (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Hetero Drugs Limited (India), TAPI NL BV (Netherlands) and Tianjin Weijie Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Eletriptan Hydrobromide Drug Master Files are active?
MATRIX PHARMACORP PRIVATE LTD (DMF 25076, 24504), SMS Pharmaceuticals limited (DMF 42128, 24905), APITORIA PHARMA PRIVATE LTD (DMF 31336), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 24528), Hetero Drugs Limited (DMF 26099), TAPI NL BV (DMF 22912) and Tianjin Weijie Pharmaceutical Co., Ltd. (DMF 30338). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Eletriptan Hydrobromide records mean?
2 organisations have only inactive Type II DMFs for Eletriptan Hydrobromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Eletriptan Hydrobromide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Eletriptan Hydrobromide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.